Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

Updated safety phase I trial of anti-LAG-3 alone and in combination with anti-PD-1 in patients with recurrent GBM. Lim, M., Ye, X., Piotrowski, A. F., Desai, A., Ahluwalia, M., Walbert, T., Fisher, J. D., Desideri, S., Nabors, L. B., Wen, P. Y., Grossman, S. A. AMER SOC CLINICAL ONCOLOGY. 2020

View details for Web of Science ID 000560368301207